Unintended Diagnosis of Von Hippel Lindau Syndrome Using Array Comparative Genomic Hybridization (CGH): Counseling Challenges Arising from Unexpected Information
- 651 Downloads
Array Comparative Genomic Hybridization (array CGH) is a powerful tool for identifying genomic imbalances and providing a diagnosis in individuals with a normal karyotype. It has been particularly useful in the investigation of individuals with developmental delay +/−, dysmorphic features and/or multiple congenital abnormalities. However, this non-targeted method of scanning the whole genome can reveal unexpected information. We present a case where array CGH identified the cause of a proband’s moderate mental retardation by discovery of a de novo deletion of chromosome 3p25.3. This deletion was shown to contain at least 25 genes including the VHL gene, the deletion or mutation of which leads to Von Hippel Lindau (VHL) syndrome. Presymptomatic testing for VHL is usually offered after appropriate genetic counseling about the implications of this condition. Therefore, scanning the genome by array CGH presents a number of challenges for the genetic counselor. We suggest that further understanding of the psychosocial effects of array CGH is needed in order for appropriate pre- and post-test counseling to be provided.
KeywordsArray Comparative Genomic Hybridization Array CGH Von Hippel Lindau Syndrome Unexpected diagnosis Chromosomal abnormality
I would like to acknowledge the following scientists of the Cytogenetics Department, Children's Hospital at Westmead: Artur Darmanian (array CGH), Luke St Heaps (FISH) and Dr Greg Peters (data analysis and interpretation).
- Charlesworth, M., Verbeke, C. S., Falk, G. A., Walsh, M., Smith, A. M., & Morris-Stiff, G. (2012). Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. Journal of Gastrointestinal Surgery, 16(7), 1422–1428.Google Scholar
- Kim, H. J., Butman, J. A., Brewer, C., Zalewski, C., Vortmeyer, A. O., Glenn, G., et al. (2005). Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. Journal of Neurosurgery, 102(3), 503–512.PubMedCrossRefGoogle Scholar
- Klungland, A., Rosewell, I., Hollenbach, S., Larsen, E., Daly, G., Epe, B., et al. (1999). Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proceedings of the National Academy of Sciences of the United States of America, 96(23), 13300–13305.PubMedCrossRefGoogle Scholar
- Lu, X., Shaw, C. A., Patel, A., Li, J., Cooper, M. L., Wells, W. R., et al. (2007). Clinical Implementation of chromosomal microarray analysis: summary of 2513. Postnatal Cases, PloS One, 2(3), e327.Google Scholar
- Peshkin, B. N., DeMarco, T. A., Garber, J. E., Valdimarsdottir, H. B., Patenaude, A. F., Schneider, K. A., et al. (2009). Brief Assessment of Parent’s Attitudes Toward Testing Minor Children for Hereditary Breast/Ovarian Cancer Genes: Development and Validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). Journal of Pediatric Psychology, 34(6), 627–638.PubMedCrossRefGoogle Scholar
- Pichert, G., Mohammed, S. N., Ahn, J. W., Ogilvie, C. M., & Izatt, L. (2011). Unexpected findings in cancer predisposition genes detected by array comparative genomic hybridisation: what are the issues? Journal of Medical Genetics, 48(8), 535–539.Google Scholar
- Pohjola, P., de Leeuw, N., Penttinen, M., Kaariainen, H., (2009). Terminal 3p deletions in two families – correlation between molecular karyotype and phenotype. American Journal of Medical Genetics – Part A, 152A, 441–446.Google Scholar
- Priesemann, M., Davies, K. M., Perry, L. A., Drake, W. M., Chew, S. L., Monson, J. P., et al. (2006). Benefits of screening in von Hippel-Lindau disease-comparison of morbidity associated with initial tumours in affected parents and children. Hormone Research in Pædiatrics, 66, 1–5.Google Scholar
- Schwarzbraun, T., Obenauf, A. C., Langmann, A., Gruber-Sedlmayr, U., Wagner, K., Speicher, M. R., et al. (2009). Predictive, Diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing. Journal of Medical Genetics, 46, 341–344.PubMedCrossRefGoogle Scholar
- Sessa, A., Battini, G., Meroni, M., Pitingolo, F., Righetti, M., Ciotti, P., et al. (2005). Multifocal Bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation. Journal of Nephrology, 18(2), 209–212.PubMedGoogle Scholar
- Vermeer, S., Koolen, D. A., Visser, G., Brackel, H. J., van der Burgt, I., de Leeuw, N., et al. (2007). A Novel microdeletion in 1(p34.2p34.3), involving the SLC2A1 (GLUT1) gene, and severe delayed development. Developmental Medicine and Child Neurology, 49(5), 380–384.Google Scholar